2024-05-15T08:30:32-05:00 2023-12-31 521446779 JOHNSON LAMBERT LLP 4242 SIX FORKS ROAD SUITE 1500 RALEIGH NC 27609 990 2023-01-01 861991878 THE 15 WHITE COATS INC 15WH 2023511664 406 GRETNA BLVD 2944 GRETNA LA 70053 DR RUSSELL LEDET PRESIDENT 2023511664 2024-05-14 1 DR RUSSELL LEDET 999009999 0 J CALVIN MARKS P01226973 9197196400 0 AAL1 IAL1 2023 2023-04-26 12:10:37Z X DR RUSSELL J LEDET 406 GRETNA BLVD 2944 GRETNA LA 70053 413709 0 X WWW.THE15WHITECOATS.ORG X 2021 LA TO PROMOTE DIVERSITY AND INCLUSION IN MEDICINE VIA REPRESENTATION AND FINANCIAL AID. 4 4 1 0 0 0 92028 358395 0 0 54 0 -3174 1429 88908 359824 0 27439 0 0 0 40267 0 0 0 40567 160872 40567 228578 48341 131246 106175 229880 8750 213 97425 229667 TO PROMOTE CULTURAL IMAGERY IN LEARNING SPACES, PROVIDE ECONOMIC SUPPORT TO MINORITIES ASPIRING TO BE PHYSICIANS, AND TO PROMOTE CULTURALLY-APPROPRIATE LITERATURE ACCESS IN LEARNING SPACES. 0 0 192943 27439 PROVIDE SCHOLARSHIPS TO MEDICAL SCHOOL APPLICANTS AND STUDENTS. 192943 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 1 0 0 DE LA X DR RUSSELL J LEDET 2023511664 406 GRETNA BLVD 2944 GRETNA LA 70053 DR RUSSELL J LEDET MD PHD MBA PRESIDENT 30.00 X X 0 0 0 DR SYDNEY C LABAT MD VICE PRESIDENT 1.00 X X 0 0 0 DR RACHEL M TURNER MD DIRECTOR 1.00 X 0 0 0 BRIAN E WASHINGTON JR DIRECTOR 1.00 X 0 0 0 LISA BATISTE EXECUTIVE DIRECTOR 40.00 X 36923 0 0 36923 0 0 0 0 0 0 0 358395 358395 55271 53885 1386 1386 43 43 43 359824 0 0 1429 27439 27439 36923 36923 3344 3344 8697 8697 4600 4600 12873 12873 46781 46781 13344 13344 8994 8994 343 343 5886 5886 801 801 TRAINING 52909 52909 TAXES & LICENSES 5046 5046 DUES & SUBSCRIPTIONS 399 399 GIFTS 199 199 228578 192943 35635 0 106175 226675 4006 801 0 3205 106175 229880 8750 213 8750 213 X 97425 229667 97425 229667 106175 229880 131246 996 0 X 0 0 0 X 27541 92028 358395 477964 27541 92028 358395 477964 190439 287525 54 54 43 43 478061 94779 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4006 801 3205 3205 1 HIGHER EDUCATION & STUDY AID GRANTS 49 27439 PART I, LINE 2: ALL GRANT RECIPIENTS MUST COMMIT TO COMPLETING 80% OF COHORT PROGRAMMING AND BEGIN BY SPECIFIC DATES DEFINED ANNUALLY. RECIPIENTS ARE SUBJECT TO AN INTERVIEW PROCESS AND MONTHLY MENTOR MEETINGS TO ENSURE FUNDS ARE BEING USED TO THE FULLEST POTENTIAL. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT FORM 990 IS DISTRIBUTED TO ALL MEMBERS OF THE BOARD OF DIRECTORS AND A DEDICATED SESSION IS SCHEDULED AT THE NEXT BOARD MEETING TO COLLECTIVELY REVIEW, FOCUSING ON KEY AREAS SUCH AS FINANCIAL STATEMENTS, DISCLOSURES, AND COMPLIANCE WITH NONPROFIT REGULATIONS. THE BOARD MUST APPROVE THE FORM 990 BY A MAJORITY VOTE. AFTER APPROVAL BY THE BOARD OF DIRECTORS AN EXTERNAL ADVISOR REVIEWS THE DOCUMENT TO ENSURE THAT IT ALIGNS WITH BEST PRACTICES FOR FINANCIAL REPORTING AND COMPLIANCE. AFTER INCORPORATING ALL FINAL AMENDMENTS AND FEEDBACK FROM THE EXTERNAL ADVISOR, THE BOARD OF DIRECTORS GIVE THE FINAL APPROVAL FOR SUBMISSION. FORM 990, PART VI, SECTION B, LINE 15A A THOROUGH EVALUATION OF THE EXECUTIVE DIRECTOR ROLE WAS CONDUCTED TO DEFINE ITS SCOPE, RESPONSIBILITIES, AND EXPECTED CONTRIBUTIONS TO THE ORGANIZATION. THE COMPENSATION COMMITTEE CONDUCTED EXTENSIVE RESEARCH TO UNDERSTAND THE PREVAILING MARKET RATES FOR EXECUTIVE DIRECTOR COMPENSATION GIVEN SIMILAR RESPONSIBILITIES, QUALIFICATIONS, AND EXPERIENCE LEVELS. THIS INCLUDES BENCHMARKING AGAINST COMPARABLE ORGANIZATIONS HELPS ENSURE THAT THE COMPENSATION PACKAGE IS COMPETITIVE AND ALIGNS WITH INDUSTRY STANDARDS. THE BOARD OF DIRECTORS ANNUALLY REVIEWS, DELIBERATES, AND APPROVES THE EXECUTIVE DIRECTOR COMPENSATION PACKAGE TO ENSURE A COMPETITIVE SALARY THAT ALIGNS WITH THE ORGANIZATION'S GOALS AND VALUES. THE MOST RECENT REVIEW OCCURRED IN JULY 2023. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND INTERNAL FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART VI, LINE 12A: THE 15 WHITE COATS ENACTED A CONFLICT OF INTEREST POLICY IN MAY 2024. THE ORGANIZATION CONSTANTLY EVALUATES AND ENFORCES THE COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY BY REQUIRING THE ANNUAL DISCLOSURE, IN WRITING, OF ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. IF A CONFLICT WERE TO ARISE, THE INDIVIDUAL IN QUESTION WOULD RECUSE THEMSELVES FROM ALL BOARD BUSINESS REGARDING THE CONFLICT AND THE ORGANIZATION WOULD DOCUMENT THE CONFLICT AND ALL MINUTES REGARDING THE ISSUE IN QUESTION. VIOLATIONS OF THIS POLICY MAY RESULT IN DISCIPLINARY ACTION, INCLUDING REMOVAL FROM OFFICE OR TERMINATION OF EMPLOYMENT OR VOLUNTEER POSITION, AS WELL AS LEGAL ACTION, IF WARRANTED. FORM 990, PART VI, LINE 13: A WRITTEN WHISTLEBLOWER POLICY WAS ENACTED BY THE 15 WHITE COATS IN MAY 2024.